Neonatal withdrawal syndrome from maternal use of drugs of addiction (Q45995): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: P96.1 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 14:17, 13 August 2026
Intrauterine exposure to addictive drugs can lead to neonatal withdrawal symptoms. Withdrawal symptoms are usually neurological, preventing normal autonomic function. The clinical presentation of drug withdrawal is variable and dependent on several factors, such as, the type and dose of drug used and rate of metabolism and excretion of the mother and infant.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | KD35 |
||
| English | Neonatal withdrawal syndrome from maternal use of drugs of addiction |
Intrauterine exposure to addictive drugs can lead to neonatal withdrawal symptoms. Withdrawal symptoms are usually neurological, preventing normal autonomic function. The clinical presentation of drug withdrawal is variable and dependent on several factors, such as, the type and dose of drug used and rate of metabolism and excretion of the mother and infant. |
Statements
CID11:KD35
0 references
dki-india-KD35
0 references
Concluído
0 references
13 August 2026
0 references
